NASDAQ:ALT
Altimmune, Inc. Stock News
$8.01
-0.89 (-10.00%)
At Close: May 17, 2024
Investors who lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT
06:03pm, Saturday, 18'th May 2024
NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, NY / ACCESSWIRE / May 18, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
3 Monster Stocks in the Making You Can Buy Right Now
06:47am, Saturday, 18'th May 2024
Altimmune could have a blockbuster weight-loss drug on the way. Axsome Therapeutics has two products on the market plus multiple promising-pipeline programs.
Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
01:15pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
July 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
01:00pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
July 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
12:00pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit - ALT
11:55am, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
11:06am, Friday, 17'th May 2024
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this s
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
06:15am, Friday, 17'th May 2024
With innovation, millions of retiring baby boomers, demand for better care, patent cliffs, gene-editing, massive interest in weight-loss treatments, and an increase in mergers, biotech stocks to buy h
Shareholders that lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT
11:15pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Class Action Filed Against Altimmune, Inc. (ALT) - July 5, 2024 Deadline to Join - Contact Levi & Korsinsky
10:55pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Investors who lost money on Altimmune, Inc.(ALT) should contact Levi & Korsinsky about pending Class Action - ALT
05:45pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
Shareholders of Altimmune, Inc. Should Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights – ALT
05:45pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
04:45pm, Thursday, 16'th May 2024
BENSALEM, Pa. , May 16, 2024 /PRNewswire/ -- Law Offices of Howard G.
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow
